December 2016
Dear Colleague,
This is the fifth edition of our newsletter titled HER2-Positive Breast Cancer Updates. In this issue, we provide articles on such topics as elevated troponin levels and their association with trastuzumab-related cardiac dysfunction; how higher vitamin D levels may lead to better outcomes in patients with breast cancer; and the use of ribociclib as first-line therapy for hormone receptor-positive breast cancer. Please share this newsletter with your colleagues and don’t hesitate to get in touch with me with your comments or suggestions through the editors of the Journal of the Advanced Practitioner in Oncology, or JADPRO, at editor@advancedpractitioner.com at any time.
Until next time, take a look at the links I’ve gathered for you here. I hope you find this newsletter to be a useful resource in your practice.
Heather Greene, MSN, FNP, AOCN®
The West Cancer Center
Memphis, Tennessee
